Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · MNQ

Stimulator, Hypoglossal Nerve, Implanted, Apnea

FDA classification: Unknown. Device class 3.

Product / regulatory recordCompanyPathwayDecision dateSource
Inspire Medical SystemsPMA supplementNov 5, 2026FDA
Inspire Medical SystemsPMA supplementOct 26, 2026FDA
Model 3150 IPGP130008/S147
Inspire Medical SystemsPMA supplementOct 22, 2026FDA
Model 3150 IPGP130008/S146
Inspire Medical SystemsPMA supplementOct 13, 2026FDA
Inspire Medical SystemsPMA supplementAug 28, 2026FDA
Inspire Medical SystemsPMA supplementAug 28, 2026FDA
Inspire Medical SystemsPMA supplementAug 17, 2026FDA
Inspire Medical SystemsPMA supplementAug 11, 2026FDA
Genio System 2.1P240024/S004
Nyxoah S.A.PMA supplementJul 30, 2026FDA
Inspire Medical SystemsPMA supplementJul 10, 2026FDA
aura6000 systemP250013/S002
LivaNova USA, Inc.PMA supplementJun 18, 2026FDA
Genio System 2.1P240024/S003
Nyxoah S.A.PMA supplementJun 8, 2026FDA
Inspire Medical SystemsPMA supplementMay 28, 2026FDA
aura6000 systemP250013/S001
LivaNova USA, Inc.PMA supplementApr 30, 2026FDA
Inspire Medical SystemsPMA supplementApr 16, 2026FDA
LivaNova USA, Inc.PMA approvalMar 18, 2026FDA
Inspire Medical SystemsPMA supplementMar 13, 2026FDA
Inspire Medical SystemsPMA supplementFeb 23, 2026FDA
Inspire Medical SystemsPMA supplementFeb 6, 2026FDA
Inspire Medical SystemsPMA supplementJan 30, 2026FDA
Inspire Medical SystemsPMA supplementDec 17, 2025FDA
Genio System 2.1P240024/S002
Nyxoah S.A.PMA supplementNov 6, 2025FDA
Inspire Medical SystemsPMA supplementOct 22, 2025FDA
Inspire Medical SystemsPMA supplementOct 21, 2025FDA
Genio System 2.1P240024/S001
Nyxoah S.A.PMA supplementOct 3, 2025FDA
Inspire Medical SystemsPMA supplementSep 29, 2025FDA
Nyxoah S.A.PMA approvalAug 8, 2025FDA
Inspire Medical SystemsPMA supplementJul 21, 2025FDA
Inspire Medical SystemsPMA approvalApr 30, 2014FDA
Source information

Follow the FDA links to view the original records.

All device categories